Twist Bioscience Corporation
TWST | NASDAQ
$139.91
-$12.87 (-8.42%)
Nov 2, 2026, 10:35 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 376.57M | 312.97M | 245.11M | 203.57M | 132.33M | 90.1M |
Cost of Revenue | 185.57M | 179.63M | 155.38M | 119.33M | 80.62M | 61.41M |
Gross Profit | 191M | 133.35M | 89.73M | 84.24M | 51.71M | 28.69M |
Operating Income | -136.26M | -220.83M | -217.16M | -234.78M | -152.73M | -140.08M |
Interest Income | 11.36M | 15.34M | 14.37M | 3.06M | 435K | 1.5M |
Pretax Income | -76.95M | -208.17M | -203.47M | -228.27M | -154.03M | -139.55M |
Net Income | -77.67M | -208.73M | -204.62M | -217.86M | -152.1M | -139.93M |
Selling & General & Admin | 246.98M | 218.4M | 189.74M | 212.95M | 135.9M | 103.27M |
Research & Development | 80.29M | 90.85M | 106.89M | 120.31M | 69.07M | 43.01M |
Other Expenses | n/a | 44.93M | 10.26M | -14.25M | -534K | 22.5M |
Operating Expenses | 327.26M | 354.18M | 306.89M | 319.01M | 204.44M | 168.77M |
Interest Expense | n/a | 29K | 5K | 80K | 367K | 787K |
Selling & Marketing Expenses | 7M | n/a | 2.9M | n/a | n/a | n/a |
Cost & Expenses | 512.83M | 533.81M | 462.27M | 438.34M | 285.06M | 230.18M |
Income Tax Expense | 719K | 560K | 1.15M | -10.41M | -1.93M | 382K |
Shares Outstanding (Basic) | 59.81M | 58.02M | 56.89M | 53.89M | 48.25M | 39.19M |
Shares Outstanding (Diluted) | 59.81M | 58.02M | 56.89M | 53.89M | 48.25M | 39.19M |
EPS (Basic) | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 |
EPS (Diluted) | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | -3.57 |
EBITDA | -52.1M | -176.71M | -174.15M | -211.68M | -143.91M | -132.09M |
EBIT | -76.95M | -208.14M | -203.46M | -228.19M | -153.66M | -138.76M |
Depreciation & Amortization | 24.85M | 31.43M | 29.31M | 16.51M | 9.75M | 6.68M |
Add to Watchlist
Select watchlists to add or remove TWST